Epigenetics in Cardiovascular Disease: Volume 24 in Translational Epigenetics

Trygve Tollefsbol (Editor), Yvan Devaux (Editor), Emma Louise Robinson (Editor)

Research output: Book/ReportBookpeer-review


Epigenetics in Cardiovascular Disease, a new volume in the Translational Epigenetics series, offers a comprehensive overview of the epigenetics mechanisms governing cardiovascular disease development, as well as instructions in research methods and guidance in pursing new studies. More than thirty international experts provide an (i) overview of the epigenetics mechanisms and their contribution to cardiovascular disease development, (i) high-throughput methods for RNA profiling including single-cell RNA-seq, (iii) the role of nucleic acid methylation in cardiovascular disease development, (iv) epigenetic actors as biomarkers and drug targets, (v) and the potential of epigenetics to advance personalized medicine. Here, readers will discover strategies to combat research challenges, improve quality of their epigenetic research and reproducibility of their findings. Additionally, discussion of assay and drug development for personalized healthcare pave the way for a new era of understanding in cardiovascular disease.

Original languageEnglish
Number of pages471
ISBN (Electronic)978-0-12-822259-1
ISBN (Print)978-0-12-822258-4
Publication statusPublished - 6 Mar 2021

Publication series

NameTranslational Epigenetics


Dive into the research topics of 'Epigenetics in Cardiovascular Disease: Volume 24 in Translational Epigenetics'. Together they form a unique fingerprint.

Cite this